SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-021961
Filing Date
2023-05-15
Accepted
2023-05-15 07:11:00
Documents
85
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ortx-20230331.htm   iXBRL 10-Q 3502974
2 EX-31.1 ortx-ex31_1.htm EX-31.1 19290
3 EX-31.2 ortx-ex31_2.htm EX-31.2 19321
4 EX-32.1 ortx-ex32_1.htm EX-32.1 15696
  Complete submission text file 0000950170-23-021961.txt   12749129

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ortx-20230331_def.xml EX-101.DEF 220513
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ortx-20230331.xsd EX-101.SCH 68472
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ortx-20230331_lab.xml EX-101.LAB 538377
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ortx-20230331_pre.xml EX-101.PRE 404254
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ortx-20230331_cal.xml EX-101.CAL 68732
79 EXTRACTED XBRL INSTANCE DOCUMENT ortx-20230331_htm.xml XML 2729601
Mailing Address 245 HAMMERSMITH ROAD, 3RD FLOOR LONDON X0 W6 8PW
Business Address 245 HAMMERSMITH ROAD, 3RD FLOOR LONDON X0 W6 8PW 011-44-0-203-3846700
Orchard Therapeutics plc (Filer) CIK: 0001748907 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38722 | Film No.: 23918359
SIC: 2836 Biological Products, (No Diagnostic Substances)